Gentherm Reports 2026 Q2 Results
Gentherm delivered record quarterly revenue and raised its full-year guidance following a strong commercial performance, while also announcing a $400 million stock repurchase authorization.
View filing at SEC.gov →2 most recent filings and news items mentioning THRM. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/THRM/news?limit=20"
Pull THRM filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayGentherm delivered record quarterly revenue and raised its full-year guidance following a strong commercial performance, while also announcing a $400 million stock repurchase authorization.
View filing at SEC.gov →Theravance Biopharma signed an agreement and plan of merger with Zymeworks Inc., aiming to combine their biopharmaceutical operations. This M&A transaction signals a strategic consolidation in the therapeutic antibody sector.
View filing at SEC.gov →